Stanford team unveils Virtual Biotech with 37,000 AI agents for drug research
AI Summary- Stanford researchers led by Professor James Zhou developed Virtual Biotech for collaborative AI drug research.
- 37,000 AI agents analyzed more than 55,000 clinical-trial results and drug-development patterns.
- Virtual Biotech has not produced a drug; researchers plan collaboration with pharmaceutical companies.